What prices were received in the Precigen (PGEN) CFO’s share sales?

The CFO’s sales used weighted average prices of $5.78 and $5.53 per share. The June 29, 2026 sale averaged $5.78, while the July 1, 2026 sale averaged $5.53, with each consisting of multiple trades across stated price ranges.

Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Financial Officer Harry Thomasian Jr. reported open-market sales of 200,000 shares of Common Stock under a 10b5-1 trading plan. On June 29, he sold 28,571 shares at a weighted average price of $5.78 per share, followed by 171,429 shares on July 1 at a weighted average price of $5.53 per share. After these transactions, he directly holds 354,535 Common Stock shares.

Insider Trade Summary 10b5-1

Net Seller: 200,000 shares ($1,113,143)

Net Sell 2 txns

Insider Thomasian Harry Jr.

Role Chief Financial Officer

Sold 200,000 shs ($1.11M)

Type	Security	Shares	Price	Value
Sale	Common Stock	171,429	$5.53	$948K
Sale	Common Stock	28,571	$5.78	$165K

Holdings After Transaction: Common Stock — 354,535 shares (Direct, null)

Footnotes (1)

Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.74 to $5.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.39 to $5.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Key Figures

Total shares sold: 200,000 shares June 29 sale: 28,571 shares at $5.78/share July 1 sale: 171,429 shares at $5.53/share +3 more

6 metrics

Total shares sold 200,000 shares Net shares sold across two transactions in 2026

June 29 sale 28,571 shares at $5.78/share Open-market sale of Common Stock

July 1 sale 171,429 shares at $5.53/share Open-market sale of Common Stock

Post-transaction holdings 354,535 shares Common Stock directly held after July 1, 2026

Higher price range $5.74–$5.86/share Weighted average sale range in one transaction

Lower price range $5.39–$5.67/share Weighted average sale range in second transaction

Key Terms

10b5-1 plan, weighted average price, open-market sale, Common Stock, +1 more

5 terms

10b5-1 plan regulatory

"Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person."

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

net-sell financial

"netBuySellDirection": "net-sell""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 06:22 PM Accepted by SEC EDGAR 07/01/2026 - 06:22 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomasian Harry Jr.

(Last)

(First)

(Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN

MARYLAND

20876

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/29/2026		S⁽¹⁾		28,571	D	$5.78⁽²⁾	525,964	D
Common Stock	07/01/2026		S⁽¹⁾		171,429	D	$5.53⁽³⁾	354,535	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.74 to $5.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.39 to $5.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

	/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Precigen (PGEN) disclose for its CFO?

Precigen (PGEN) disclosed that CFO Harry Thomasian Jr. sold 200,000 Common Stock shares. The sales occurred in two open-market transactions on June 29 and July 1, 2026, and were reported as part of a pre-arranged 10b5-1 trading plan.

On what dates did the Precigen (PGEN) CFO sell shares in this Form 4?

The Precigen CFO sold shares on June 29, 2026, and July 1, 2026. He sold 28,571 Common Stock shares on June 29 and 171,429 shares on July 1, with both transactions reported as open-market sales under a 10b5-1 plan.

How many Precigen (PGEN) shares does the CFO hold after these sales?

After the reported transactions, the CFO directly holds 354,535 Precigen Common Stock shares. This post-transaction holding reflects the remaining shares following open-market sales totaling 200,000 shares disclosed in the Form 4 filing data.

Were the Precigen (PGEN) insider sales made under a 10b5-1 trading plan?

Yes, the shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person. The footnotes explain that the transactions followed this pre-arranged plan, which schedules trades in advance under predefined conditions.

What price ranges applied to the Precigen (PGEN) CFO’s stock sales?

The Form 4 notes weighted average prices from multiple trades within specified ranges. One set of sales occurred between $5.74 and $5.86 per share, while another set occurred between $5.39 and $5.67 per share, as described in the filing footnotes.